cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
DA000185 | .o | 2 to 439 | 2 to 438 | capped | 437/437 (100 %) | 2 diff (99.6 %id) | |||
DA000502 | .vd-u | 1 to 530 | 2 to 533 | capped | 532/532 (100 %) | 1 diff (99.9 %id) | |||
DB294928 | .vd-u | 1321 to 1834 | 514 to 1 | 514/516 (99 %) | 0 diff (100 %id) | ||||
AA781788 | parathyroid gland, parathyroid tumor | .vd-u | 1610 to 1840 | 231 to 1 | 231/231 (100 %) | 0 diff (100 %id) | |||
AA312960 | Pancreas | .vd-u | 3244 to 3547 | 1 to 304 | 304/304 (100 %) | 0 diff (100 %id) | |||
AA331846 | Embryo, 8 weeks | .vd-u | 3093 to 3371 | 1 to 280 | 280/280 (100 %) | 1 diff (99.7 %id) | |||
AA334958 | .vl-u | 599 to 739 | 1 to 140 | tiling clone, | 140/140 (100 %) | 1 diff (99.3 %id) | |||
AA380515 | .o | 637 to 833 | 1 to 197 | 197/197 (100 %) | 2 diff (99.0 %id) | ||||
AA381647 | .vj | 1 to 339 | 1 to 340 | S12X V70X K90X T92X M99L ... | tiling clone, | 340/340 (100 %) | 3 diff (99.2 %id) | ||
AB034691 | .i | 1384 to 1598 | 1 to 215 | 215/215 (100 %) | 0 diff (100 %id) | ||||
AB440195 | colon | .n | 1 to 1736 | 1 to 1736 | exact | tiling clone, | 1736/1736 (100 %) | 0 diff (100 %id) | |
AB451266 | .a | 508 to 2297 | 1 to 1790 | 1790/1791 (99 %) | 2 diff (99.9 %id) | ||||
BP194188 | brain | .vg | 1 to 585 | 1 to 581 | Q109X Q117X S142F | 581/581 (100 %) | 7 diff (98.8 %id) | ||
AI903243 | breast | .vk | 8 to 521 | 521 to 3 | 519/525 (98 %) | 0 diff (100 %id) | |||
AI903246 | breast | .vk | 7 to 521 | 1 to 522 | 522/632 (82 %) | 9 diff (98.6 %id) | |||
AI903248 | breast | .vk | 7 to 521 | 1 to 516 | tiling clone, | 516/518 (99 %) | 2 diff (99.7 %id) | ||
AI903463 | breast | .vk | 1 to 521 | 522 to 3 | tiling clone, | 520/546 (95 %) | 0 diff (100 %id) | ||
AI903465 | breast | .vk | 7 to 279 | 1 to 272 | 272/272 (100 %) | 3 diff (98.9 %id) | |||
AI903467 | breast | .vk | 7 to 521 | 1 to 513 | 513/548 (93 %) | 4 diff (99.3 %id) | |||
AI940069 | colon | .vd-u | 1401 to 1604 | 210 to 7 | 204/210 (97 %) | 0 diff (100 %id) | |||
AK054578 | .vd-u | 1 to 1835 | 2 to 1838 | tiling clone, available from FLJ, | 1838/1838 (100 %) | 2 diff (99.9 %id) | |||
AK074705 | .o | 1486 to 2511 | 1 to 1026 | available from FLJ, | 1026/1026 (100 %) | 3 diff (99.8 %id) | |||
AK225809 | Kidney | .e | 2 to 2581 | 1 to 2581 | T249M | tiling clone, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 2581/2581 (100 %) | 2 diff (100.0 %id) |
AK296305 | thalamus | .r | 329 to 1829 | 1 to 1501 | exact | tiling clone, | 1501/1501 (100 %) | 1 diff (100.0 %id) | |
AK299295 | .o | 472 to 2099 | 1 to 1629 | 1629/1629 (100 %) | 2 diff (99.9 %id) | ||||
AK301483 | synovial membrane tissue from rheumatoidarthritis | .q | 1 to 1358 | 1 to 1358 | exact | tiling clone, | 1358/1358 (100 %) | 0 diff (100 %id) | |
AK303684 | kidney, tumor tissue | .va | 95 to 1229 | 1 to 1135 | tiling clone, | 1135/1135 (100 %) | 1 diff (100.0 %id) | ||
AK315243 | kidney, tumor tissue | .f | 337 to 2315 | 1 to 1981 | tiling clone, | 1981/1981 (100 %) | 3 diff (99.9 %id) | ||
AK316111 | thalamus | .s | 181 to 1493 | 1 to 1313 | exact | tiling clone, | 1313/1313 (100 %) | 0 diff (100 %id) | |
DA020405 | .o | 117 to 691 | 2 to 575 | capped | 574/574 (100 %) | 1 diff (99.9 %id) | |||
DA024776 | .vb | 1 to 561 | 2 to 562 | tiling clone, capped | 561/561 (100 %) | 1 diff (99.9 %id) | |||
AW363395 | colon | .i | 780 to 1206 | 447 to 20 | 429/447 (95 %) | 10 diff (97.8 %id) | |||
AW363402 | colon | .i | 780 to 1210 | 1 to 432 | 432/432 (100 %) | 3 diff (99.4 %id) | |||
AW363404 | colon | .i | 780 to 1210 | 1 to 432 | 432/432 (100 %) | 3 diff (99.4 %id) | |||
AW376554 | colon | .vd-u | 2694 to 2994 | 301 to 1 | 301/301 (100 %) | 1 diff (99.7 %id) | |||
AW577332 | breast | .vm-u | 602 to 1130 | 23 to 559 | 537/559 (96 %) | 6 diff (99.0 %id) | |||
AW812992 | stomach | .vd-u | 317 to 1029 | 12 to 714 | 703/758 (92 %) | 19 diff (97.5 %id) | |||
AW965283 | .vd-u | 3094 to 3495 | 1 to 403 | 403/403 (100 %) | 8 diff (98.1 %id) | ||||
BC032656 | Uterus, leiomyosarcoma | .h | 423 to 2543 | 11 to 2132 | tiling clone, available from MGC, AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 2122/2122 (100 %) | 1 diff (100.0 %id) | |
BE765554 | nervous_tumor | .vt-u | 1 to 243 | 1 to 244 | exact | tiling clone, | 244/244 (100 %) | 2 diff (99.2 %id) | |
BE933332 | head_neck | .d | 516 to 1112 | 1 to 593 | 593/593 (100 %) | 17 diff (97.2 %id) | |||
BF356059 | head_neck | .vu-u | 1 to 180 | 1 to 180 | L25F R35G V47A | tiling clone, | 180/191 (94 %) | 4 diff (98.0 %id) | |
BF367702 | placenta_normal | .vf-u | 413 to 518 | 105 to 1 | 105/124 (84 %) | 1 diff (99.2 %id) | |||
BF798702 | colon_ins | .vk | 321 to 820 | 507 to 11 | N53T L54C L55* | tiling clone, | Submitted on the opposite strand | 497/507 (98 %) | 7 diff (98.7 %id) |
BF811147 | colon_ins | .o | 558 to 804 | 1 to 247 | 247/258 (95 %) | 2 diff (99.3 %id) | |||
BG897197 | cartilage | .o | 23 to 439 | 86 to 502 | 417/434 (96 %) | 6 diff (98.7 %id) | |||
BG900238 | cartilage | .vm-u | 159 to 450 | 87 to 378 | exact | 292/311 (93 %) | 1 diff (99.7 %id) | ||
BM360880 | rectum | .o | 1055 to 1220 | 1 to 166 | 166/166 (100 %) | 0 diff (100 %id) | |||
AV758440 | bone marrow | .vm-u | 686 to 1154 | 66 to 535 | 470/487 (96 %) | 3 diff (99.4 %id) | |||
BQ307832 | breast | .o | 486 to 597 | 1 to 113 | 113/113 (100 %) | 4 diff (96.5 %id) | |||
BQ327012 | colon_normal | .d | 563 to 1038 | 1 to 477 | 477/477 (100 %) | 18 diff (96.3 %id) | |||
BQ332932 | lung_tumor | .vl-u | 2584 to 2911 | 1 to 328 | 328/328 (100 %) | 12 diff (96.4 %id) | |||
DA121764 | cerebellum | .o | 81 to 640 | 2 to 560 | capped | 559/559 (100 %) | 1 diff (99.9 %id) | ||
DA246335 | brain | .vl-u | 1 to 563 | 2 to 567 | tiling clone, capped | 566/566 (100 %) | 7 diff (98.8 %id) | ||
DA297788 | hippocampus | .h | 1479 to 2041 | 2 to 564 | capped | 563/563 (100 %) | 4 diff (99.3 %id) | ||
DA305286 | hippocampus | .vb | 25 to 599 | 2 to 576 | exact | tiling clone, capped | 575/575 (100 %) | 0 diff (100 %id) | |
DA310886 | hippocampus | .e | 1 to 548 | 2 to 547 | tiling clone, capped | 546/546 (100 %) | 3 diff (99.5 %id) | ||
DA318985 | hippocampus | .d | 1 to 573 | 2 to 574 | tiling clone, capped | 573/573 (100 %) | 4 diff (99.4 %id) | ||
DA368184 | subthalamic nucleus | .vh | 248 to 821 | 2 to 576 | exact | tiling clone, capped | 575/575 (100 %) | 1 diff (99.9 %id) | |
DA376784 | thalamus | .l | 88 to 640 | 2 to 554 | capped | 553/553 (100 %) | 1 diff (99.9 %id) | ||
DA387394 | thalamus | .s | 659 to 1235 | 2 to 580 | capped | 579/579 (100 %) | 2 diff (99.7 %id) | ||
DA388466 | thalamus | .va | 66 to 629 | 2 to 565 | capped | 564/564 (100 %) | 0 diff (100 %id) | ||
DA391880 | thalamus | .vi | 1 to 430 | 167 to 596 | S127F P133S | tiling clone, capped | 430/595 (72 %) | 8 diff (98.7 %id) | |
DA392182 | thalamus | .va | 64 to 653 | 2 to 591 | capped | 590/590 (100 %) | 0 diff (100 %id) | ||
DA393779 | thalamus | .o | 113 to 697 | 2 to 586 | capped | 585/587 (99 %) | 3 diff (99.5 %id) | ||
DA394180 | thalamus | .va | 97 to 692 | 2 to 597 | capped | 596/596 (100 %) | 0 diff (100 %id) | ||
DA394991 | thalamus | .vm-u | 1 to 585 | 2 to 586 | exact | tiling clone, capped | 585/585 (100 %) | 0 diff (100 %id) | |
DA397930 | thalamus | .va | 58 to 629 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
DA398292 | thalamus | .r | 330 to 899 | 2 to 571 | capped | 570/570 (100 %) | 0 diff (100 %id) | ||
DA399372 | thalamus | .d | 602 to 1168 | 2 to 568 | capped | 567/567 (100 %) | 2 diff (99.7 %id) | ||
DA400182 | thalamus | .vr | 1 to 494 | 2 to 495 | tiling clone, capped | 494/494 (100 %) | 3 diff (99.4 %id) | ||
DA400285 | thalamus | .vq | 1 to 560 | 2 to 561 | N46D | tiling clone, capped | 560/560 (100 %) | 2 diff (99.7 %id) | |
DA401050 | thalamus | .s | 71 to 646 | 2 to 577 | capped | 576/576 (100 %) | 0 diff (100 %id) | ||
DA401171 | thalamus | .r | 1 to 563 | 2 to 565 | capped | 564/564 (100 %) | 2 diff (99.7 %id) | ||
DA401220 | thalamus | .o | 114 to 681 | 2 to 570 | capped | 569/569 (100 %) | 4 diff (99.3 %id) | ||
DA402429 | thalamus | .d | 2 to 523 | 2 to 526 | tiling clone, capped | 525/526 (99 %) | 7 diff (98.7 %id) | ||
DA402921 | thalamus | .va | 42 to 626 | 2 to 586 | capped | 585/585 (100 %) | 0 diff (100 %id) | ||
DA402925 | thalamus | .o | 97 to 681 | 2 to 585 | capped | 584/584 (100 %) | 4 diff (99.4 %id) | ||
DA403780 | thalamus | .s | 56 to 533 | 2 to 479 | capped | 478/478 (100 %) | 1 diff (99.8 %id) | ||
DA404100 | thalamus | .va | 66 to 609 | 2 to 545 | capped | 544/544 (100 %) | 0 diff (100 %id) | ||
DA406350 | thalamus | .vl-u | 790 to 1351 | 2 to 564 | tiling clone, capped | 563/563 (100 %) | 1 diff (99.9 %id) | ||
DA407532 | thalamus | .s | 182 to 738 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | ||
DA408316 | thalamus | .o | 886 to 1412 | 29 to 555 | capped | 527/554 (95 %) | 8 diff (98.6 %id) | ||
DA409175 | thalamus | .s | 182 to 747 | 2 to 567 | capped | 566/566 (100 %) | 0 diff (100 %id) | ||
DA409492 | thalamus | .vc | 1 to 562 | 2 to 563 | exact | tiling clone, capped | 562/562 (100 %) | 0 diff (100 %id) | |
DA410007 | thalamus | .vh | 160 to 725 | 2 to 567 | tiling clone, capped | 566/566 (100 %) | 0 diff (100 %id) | ||
DA410796 | thalamus | .r | 1 to 636 | 2 to 637 | tiling clone, capped | 636/636 (100 %) | 1 diff (99.9 %id) | ||
DA411708 | thalamus | .s | 106 to 436 | 2 to 332 | capped | 331/331 (100 %) | 0 diff (100 %id) | ||
DA412399 | thalamus | .vn | 1 to 571 | 2 to 572 | tiling clone, capped | 571/571 (100 %) | 0 diff (100 %id) | ||
DA414161 | thalamus | .s | 1 to 563 | 2 to 564 | tiling clone, capped | 563/563 (100 %) | 0 diff (100 %id) | ||
DA415587 | thalamus | .r | 54 to 717 | 2 to 666 | capped | 665/665 (100 %) | 1 diff (99.9 %id) | ||
BX103333 | liver and spleen | .o | 134 to 827 | 1 to 696 | 696/696 (100 %) | 4 diff (99.5 %id) | |||
BX114437 | liver and spleen | .vd-u | 1382 to 1849 | 1 to 468 | tiling clone, AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 468/468 (100 %) | 0 diff (100 %id) | |
BX648364 | human esophagus tumor | .d | 663 to 3866 | 1 to 3202 | tiling clone, available from DKFZ, AAA | Possibly primed on the genome, locally A rich (9/9 A in genome downstream of last aligned base) | 3202/3202 (100 %) | 5 diff (99.9 %id) | |
AV741028 | cord Blood | .o | 2654 to 3156 | 496 to 5 | Submitted on the opposite strand | 492/496 (99 %) | 0 diff (100 %id) | ||
AV741030 | cord Blood | .o | 2654 to 3096 | 434 to 5 | Submitted on the opposite strand | 430/434 (99 %) | 0 diff (100 %id) | ||
CN261409 | embryonic stem cells, DMSO-treated H9 cellline | .o | 47 to 610 | 1 to 565 | 565/565 (100 %) | 1 diff (99.9 %id) | |||
CN261410 | embryonic stem cells, DMSO-treated H9 cellline | .o | 2291 to 2891 | 1 to 600 | 600/600 (100 %) | 2 diff (99.7 %id) | |||
CN261411 | embryonic stem cells, cell lines H1, H7, andH9 | .o | 156 to 728 | 1 to 575 | 575/575 (100 %) | 4 diff (99.4 %id) | |||
CN261412 | embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells | .d | 401 to 1136 | 1 to 736 | tiling clone, | 736/736 (100 %) | 3 diff (99.6 %id) | ||
CN261414 | embryonic stem cells, cell lines H1, H7, andH9 | .o | 1019 to 1580 | 1 to 561 | 561/561 (100 %) | 1 diff (99.9 %id) | |||
CN261415 | embryonic stem cells, cell lines H1, H7, andH9 | .e | 1125 to 1802 | 1 to 678 | 678/678 (100 %) | 0 diff (100 %id) | |||
CN261416 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .e | 1759 to 2380 | 1 to 622 | 622/622 (100 %) | 0 diff (100 %id) | |||
CN430307 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .vl-u | 2334 to 3032 | 1 to 699 | tiling clone, | 699/705 (99 %) | 1 diff (99.9 %id) | ||
BP221385 | colon | .vd-u | 2989 to 3561 | 1 to 573 | 573/574 (99 %) | 6 diff (99.0 %id) | |||
CR536574 | .a | 508 to 2298 | 1 to 1791 | tiling clone, | 1791/1791 (100 %) | 0 diff (100 %id) | |||
CR747336 | melanotic melanoma, skin | .i | 1325 to 1805 | 36 to 516 | 481/516 (93 %) | 6 diff (98.9 %id) | |||
DA455637 | tongue, tumor tissue | .e | 5 to 559 | 2 to 557 | capped | 556/556 (100 %) | 1 diff (99.9 %id) | ||
CV377332 | colon_normal | .d | 1631 to 1868 | 4 to 242 | 239/242 (98 %) | 18 diff (92.6 %id) | |||
AV716301 | .vm-u | 113 to 766 | 1 to 652 | P44G F45G | 652/652 (100 %) | 9 diff (98.7 %id) | |||
DA473655 | .o | 2 to 558 | 2 to 558 | capped | 557/557 (100 %) | 0 diff (100 %id) | |||
DA473738 | .l | 1 to 564 | 2 to 565 | tiling clone, capped | 564/564 (100 %) | 1 diff (99.9 %id) | |||
Z99385 | amygdala, ovary | .vd-u | 3245 to 3739 | 1 to 497 | tiling clone, | 497/497 (100 %) | 3 diff (99.4 %id) | ||
Z99386 | amygdala, ovary | .vm-u | 482 to 1154 | 676 to 4 | tiling clone, | 673/676 (99 %) | 0 diff (100 %id) | ||
DN917117 | .o | 2654 to 3206 | 40 to 593 | 554/593 (93 %) | 6 diff (99.0 %id) | ||||
DN917118 | .vm-u | 331 to 939 | 609 to 1 | 609/609 (100 %) | 2 diff (99.7 %id) | ||||
EC480268 | Prostate | .vd-u | 3411 to 3524 | 1 to 114 | 114/114 (100 %) | 0 diff (100 %id) | |||
EC484547 | Prostate | .vd-u | 3092 to 3192 | 1 to 97 | 97/97 (100 %) | 5 diff (94.9 %id) | |||
EH338968 | .vm-u | 617 to 686 | 1 to 69 | 69/69 (100 %) | 1 diff (98.6 %id) | ||||
FJ010164 | mix of human tissues: pancreatic islets,pancreas, monocytes, brain, colon, liver, kidney, skeletalmuscles, adipose tissue | .g | 1 to 1755 | 1 to 1755 | P204X | tiling clone, | 1755/1755 (100 %) | 0 diff (100 %id) | |
FJ010165 | mix of human tissues: pancreatic islets,pancreas, monocytes, brain, colon, liver, kidney, skeletalmuscles, adipose tissue | .c | 1 to 1887 | 1 to 1887 | exact | tiling clone, | 1887/1887 (100 %) | 0 diff (100 %id) | |
FJ010166 | mix of human tissues: pancreatic islets,pancreas, monocytes, brain, colon, liver, kidney, skeletalmuscles, adipose tissue | .i | 1 to 1824 | 1 to 1824 | exact | tiling clone, | 1824/1824 (100 %) | 1 diff (100.0 %id) | |
FJ010167 | mix of human tissues: pancreatic islets,pancreas, monocytes, brain, colon, liver, kidney, skeletalmuscles, adipose tissue | .b | 1 to 1902 | 1 to 1902 | exact | tiling clone, | 1902/1902 (100 %) | 0 diff (100 %id) | |
FJ010168 | brain | .m | 1 to 1541 | 1 to 1541 | exact | tiling clone, | 1541/1541 (100 %) | 0 diff (100 %id) | |
FJ010169 | brain | .j | 1 to 1553 | 1 to 1553 | L340H | tiling clone, | 1553/1553 (100 %) | 1 diff (100.0 %id) | |
FJ010170 | mix of human tissues: pancreatic islets,pancreas, monocytes, brain, colon, liver, kidney, skeletalmuscles, adipose tissue | .k | 1 to 1568 | 1 to 1568 | K348Q | tiling clone, | 1568/1568 (100 %) | 1 diff (100.0 %id) | |
FJ010171 | mix of human tissues: pancreatic islets,pancreas, monocytes, brain, colon, liver, kidney, skeletalmuscles, adipose tissue | .p | 1 to 1440 | 1 to 1440 | Q389R | tiling clone, | 1440/1440 (100 %) | 1 diff (100.0 %id) | |
FJ010172 | mix of human tissues: pancreatic islets,pancreas, monocytes, brain, colon, liver, kidney, skeletalmuscles, adipose tissue | .o | 411 to 1970 | 1 to 1560 | tiling clone, | 1560/1560 (100 %) | 0 diff (100 %id) | ||
FJ010173 | mix of human tissues: pancreatic islets,pancreas, monocytes, brain, colon, liver, kidney, skeletalmuscles, adipose tissue | .l | 13 to 1767 | 1 to 1755 | exact | tiling clone, | 1755/1755 (100 %) | 0 diff (100 %id) | |
FJ010174 | mix of human tissues: pancreatic islets,pancreas, monocytes, brain, colon, liver, kidney, skeletalmuscles, adipose tissue | .e | 57 to 2320 | 1 to 2264 | tiling clone, | 2264/2264 (100 %) | 1 diff (100.0 %id) | ||
FN048478 | breast carcinoma | .vd-u | 109 to 200 | 94 to 1 | Submitted on the opposite strand | 94/95 (98 %) | 2 diff (97.9 %id) | ||
FN049701 | breast carcinoma | .vm-u | 668 to 783 | 116 to 1 | Submitted on the opposite strand | 116/122 (95 %) | 0 diff (100 %id) | ||
FN053298 | breast carcinoma | .vl-u | 2520 to 2583 | 64 to 1 | Submitted on the opposite strand | 64/64 (100 %) | 0 diff (100 %id) | ||
FN061278 | breast carcinoma | .vm-u | 658 to 779 | 122 to 1 | Submitted on the opposite strand | 122/122 (100 %) | 0 diff (100 %id) | ||
FN076308 | breast carcinoma | .o | 1284 to 1369 | 1 to 82 | 82/83 (98 %) | 5 diff (94.0 %id) | |||
FN081658 | breast carcinoma | .vm-u | 469 to 568 | 104 to 1 | Submitted on the opposite strand | 104/105 (99 %) | 6 diff (94.3 %id) | ||
FN084448 | breast carcinoma | .vd-u | 125 to 244 | 1 to 122 | 122/127 (96 %) | 3 diff (97.7 %id) | |||
FN096460 | breast carcinoma | .vd-u | 182 to 243 | 4 to 63 | 60/66 (90 %) | 3 diff (95.5 %id) | |||
FN147712 | breast carcinoma | .o | 1346 to 1439 | 1 to 95 | 95/99 (95 %) | 2 diff (98.0 %id) | |||
GD159675 | .o | 1306 to 1478 | 1 to 174 | 174/174 (100 %) | 11 diff (93.7 %id) | ||||
GD160206 | .vv-u | 1 to 120 | 1 to 120 | R3S | tiling clone, AAA | Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) | 120/120 (100 %) | 2 diff (98.4 %id) | |
DB450717 | testis | .vh | 1 to 399 | 1 to 400 | tiling clone, | 400/400 (100 %) | 9 diff (97.8 %id) | ||
DB516182 | testis | .vm-u | 718 to 1145 | 1 to 428 | Submitted on the opposite strand | 428/430 (99 %) | 14 diff (96.8 %id) | ||
DB456031 | testis | .vh | 1 to 492 | 1 to 490 | 490/490 (100 %) | 2 diff (99.6 %id) | |||
DB521446 | testis | .vm-u | 678 to 1147 | 1 to 470 | Submitted on the opposite strand | 470/470 (100 %) | 0 diff (100 %id) | ||
DB462971 | hippocampus | .s | 167 to 645 | 1 to 478 | 478/481 (99 %) | 2 diff (99.6 %id) | |||
DB528670 | hippocampus | .vm-u | 676 to 1145 | 1 to 469 | Submitted on the opposite strand | 469/471 (99 %) | 6 diff (98.8 %id) | ||
DB474092 | hippocampus | .e | 5 to 497 | 1 to 494 | 494/494 (100 %) | 2 diff (99.6 %id) | |||
DB475273 | hippocampus | .o | 1 to 462 | 1 to 462 | tiling clone, | 462/462 (100 %) | 1 diff (99.8 %id) | ||
DB544096 | hippocampus | .vm-u | 686 to 1145 | 1 to 460 | Submitted on the opposite strand | 460/460 (100 %) | 1 diff (99.8 %id) | ||
BP236156 | coronary artery | .o | 1267 to 1708 | 1 to 442 | 442/472 (93 %) | 3 diff (99.4 %id) | |||
BY799228 | eye | .o | 2466 to 2942 | 1 to 480 | 480/480 (100 %) | 1 diff (99.8 %id) | |||
BY800230 | eye | .vd-u | 143 to 248 | 1 to 106 | 106/106 (100 %) | 0 diff (100 %id) | |||
AU118429 | whole embryo, mainly head | .o | 883 to 1753 | 2 to 872 | capped | 871/874 (99 %) | 13 diff (98.6 %id) | ||
DB356522 | whole embryo, mainly head | .o | 1931 to 2511 | 584 to 1 | 584/587 (99 %) | 26 diff (95.6 %id) | |||
AU120697 | whole embryo, mainly body | .o | 1520 to 2300 | 2 to 779 | capped | 778/783 (99 %) | 12 diff (98.5 %id) | ||
AU146694 | whole embryo, mainly body | .o | 3323 to 3875 | 552 to 1 | 552/552 (100 %) | 7 diff (98.8 %id) | |||
BJ992250 | hepatoblastoma | .vd-u | 3087 to 3511 | 427 to 1 | 427/427 (100 %) | 1 diff (99.8 %id) | |||
DA584172 | lung | .vd-u | 1275 to 1819 | 2 to 546 | tiling clone, capped | 545/545 (100 %) | 0 diff (100 %id) | ||
DB319335 | lung | .vd-u | 3010 to 3540 | 531 to 1 | 531/531 (100 %) | 0 diff (100 %id) | |||
DA590466 | lung | .e | 1 to 583 | 2 to 584 | capped | 583/583 (100 %) | 3 diff (99.5 %id) | ||
DA590774 | lung | .o | 700 to 1259 | 2 to 563 | capped | 562/567 (99 %) | 3 diff (99.5 %id) | ||
CN483425 | eye | .vf-u | 1 to 648 | 1 to 648 | exact | tiling clone, | 648/648 (100 %) | 0 diff (100 %id) | |
H08630 | whole brain | .t | 444 to 819 | 1 to 376 | tiling clone, | 376/466 (80 %) | 22 diff (95.3 %id) | ||
H08631 | whole brain | .t | 1805 to 2232 | 439 to 5 | tiling clone, | 435/439 (99 %) | 0 diff (100 %id) | ||
T53137 | fetal spleen, Spleen | .vd-u | 3153 to 3537 | 1 to 386 | 386/387 (99 %) | 4 diff (99.0 %id) | |||
T53760 | placenta | .vm-u | 782 to 1148 | 1 to 374 | fully sequenced, | 374/374 (100 %) | 8 diff (97.9 %id) | ||
T54154 | placenta | .vm-u | 1073 to 1149 | 88 to 1 | fully sequenced, | 88/88 (100 %) | 0 diff (100 %id) | ||
T81462 | liver and spleen | .vd-u | 1540 to 1807 | 280 to 1 | fully sequenced, | 280/280 (100 %) | 2 diff (99.3 %id) | ||
T81663 | liver and spleen | .vd-u | 1381 to 1570 | 1 to 195 | fully sequenced, | 195/195 (100 %) | 0 diff (100 %id) | ||
T85898 | liver and spleen | .vd-u | 1124 to 1377 | 1 to 262 | 262/263 (99 %) | 9 diff (96.6 %id) | |||
T90892 | liver and spleen | .vd-u | 1548 to 1824 | 277 to 1 | 277/277 (100 %) | 0 diff (100 %id) | |||
T87943 | lung | .o | 2551 to 2928 | 1 to 394 | 394/406 (97 %) | 24 diff (94.1 %id) | |||
T98041 | lung | .vm-u | 766 to 1093 | 330 to 1 | 330/341 (96 %) | 12 diff (96.5 %id) | |||
T98127 | lung | .vm-u | 48 to 295 | 1 to 250 | 250/255 (98 %) | 4 diff (98.5 %id) | |||
T94332 | lung | .vm-u | 793 to 1152 | 368 to 1 | 368/391 (94 %) | 11 diff (97.2 %id) | |||
T94687 | lung | .vm-u | 154 to 440 | 1 to 297 | exact | 297/302 (98 %) | 22 diff (92.8 %id) | ||
R05930 | liver and spleen | .o | 1104 to 1445 | 344 to 1 | 344/344 (100 %) | 6 diff (98.3 %id) | |||
R06032 | liver and spleen | .o | 135 to 587 | 1 to 462 | 462/464 (99 %) | 11 diff (97.7 %id) | |||
H50692 | breast | .o | 1094 to 1439 | 350 to 1 | 350/355 (98 %) | 9 diff (97.5 %id) | |||
R95680 | liver and spleen | .o | 2666 to 3004 | 1 to 345 | Submitted on the opposite strand | 345/347 (99 %) | 12 diff (96.6 %id) | ||
R97770 | liver and spleen | .vd-u | 1093 to 1535 | 9 to 464 | fully sequenced, | 456/464 (98 %) | 6 diff (98.8 %id) | ||
R97771 | liver and spleen | .vd-u | 1505 to 1835 | 340 to 1 | fully sequenced, | 340/340 (100 %) | 13 diff (96.2 %id) | ||
N54411 | liver and spleen | .vm-u | 719 to 1153 | 434 to 1 | 434/434 (100 %) | 2 diff (99.6 %id) | |||
N55259 | liver and spleen | .vd-u | 1490 to 1835 | 349 to 1 | fully sequenced, | 349/349 (100 %) | 2 diff (99.5 %id) | ||
N76867 | liver and spleen | .vd-u | 1092 to 1520 | 1 to 433 | fully sequenced, | 433/433 (100 %) | 5 diff (98.9 %id) | ||
N59093 | liver and spleen | .vm-u | 768 to 1154 | 387 to 2 | 386/387 (99 %) | 0 diff (100 %id) | |||
N59498 | liver and spleen | .vm-u | 117 to 395 | 1 to 280 | F2X | 280/290 (96 %) | 4 diff (98.7 %id) | ||
N58376 | liver and spleen | .o | 2669 to 3225 | 1 to 559 | Submitted on the opposite strand | 559/564 (99 %) | 4 diff (99.3 %id) | ||
N77963 | liver and spleen | .vm-u | 743 to 1148 | 412 to 2 | Submitted on the opposite strand | 411/417 (98 %) | 0 diff (100 %id) | ||
H84898 | melanocyte | .o | 1041 to 1439 | 399 to 1 | 399/400 (99 %) | 1 diff (99.8 %id) | |||
N50901 | multiple sclerosis lesions | .vm-u | 695 to 1147 | 452 to 1 | 452/452 (100 %) | 3 diff (99.4 %id) | |||
N71873 | cochlea, ear | .vm-u | 753 to 1153 | 401 to 1 | 401/401 (100 %) | 3 diff (99.3 %id) | |||
N66507 | cochlea, ear | .vm-u | 658 to 1153 | 497 to 1 | 497/497 (100 %) | 6 diff (98.8 %id) | |||
N68315 | cochlea, ear | .vm-u | 697 to 1147 | 474 to 17 | AAA | 458/461 (99 %) | 12 diff (97.4 %id) | ||
N71423 | liver and spleen | .vm-u | 658 to 1101 | 447 to 3 | 445/447 (99 %) | 0 diff (100 %id) | |||
N99356 | liver and spleen | .vm-u | 232 to 609 | 1 to 381 | 381/381 (100 %) | 9 diff (97.7 %id) | |||
N89802 | parathyroid gland, parathyroid tumor | .vd-u | 3320 to 3540 | 223 to 1 | fully sequenced, | 223/223 (100 %) | 1 diff (99.6 %id) | ||
W39059 | parathyroid gland, parathyroid tumor | .vd-u | 3151 to 3538 | 1 to 391 | fully sequenced, | 391/391 (100 %) | 6 diff (98.5 %id) | ||
W68649 | heart | .o | 2563 to 3158 | 1 to 598 | 598/598 (100 %) | 14 diff (97.7 %id) | |||
W68650 | heart | .o | 3503 to 3873 | 371 to 1 | 371/372 (99 %) | 0 diff (100 %id) | |||
AA016003 | heart | .vm-u | 825 to 1106 | 289 to 1 | 289/323 (89 %) | 10 diff (97.0 %id) | |||
AA062767 | heart | .vm-u | 978 to 1149 | 173 to 1 | 173/173 (100 %) | 1 diff (99.5 %id) | |||
AA082426 | heart | .vm-u | 423 to 720 | 1 to 298 | 298/301 (99 %) | 5 diff (98.4 %id) | |||
AA029451 | heart | .vm-u | 735 to 1147 | 414 to 1 | fully sequenced, | 414/414 (100 %) | 3 diff (99.3 %id) | ||
AA029516 | heart | .vm-u | 309 to 765 | 1 to 464 | fully sequenced, | 464/464 (100 %) | 9 diff (98.1 %id) | ||
AA045265 | heart | .o | 1283 to 1455 | 173 to 1 | fully sequenced, | 173/173 (100 %) | 0 diff (100 %id) | ||
AA045273 | heart | .o | 912 to 1453 | 1 to 541 | fully sequenced, | 541/541 (100 %) | 2 diff (99.7 %id) | ||
AA708723 | uterus | .vm-u | 752 to 1150 | 408 to 11 | 398/408 (97 %) | 0 diff (100 %id) | |||
AA165003 | .vm-u | 340 to 393 | 1 to 54 | 54/54 (100 %) | 0 diff (100 %id) | ||||
AA164994 | .vm-u | 339 to 394 | 1 to 56 | 56/56 (100 %) | 2 diff (96.5 %id) | ||||
AA417751 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vd-u | 2363 to 2770 | 12 to 419 | 408/419 (97 %) | 6 diff (98.6 %id) | |||
AA419628 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .o | 1012 to 1455 | 444 to 1 | 444/444 (100 %) | 1 diff (99.8 %id) | |||
AA503874 | colon | .vd-u | 3111 to 3540 | 435 to 5 | 431/435 (99 %) | 0 diff (100 %id) | |||
AA505521 | breast | .vm-u | 777 to 1151 | 374 to 1 | 374/374 (100 %) | 1 diff (99.8 %id) | |||
AA522665 | metastatic prostate bone lesion | .vm-u | 781 to 1154 | 380 to 7 | 374/380 (98 %) | 0 diff (100 %id) | |||
AA553841 | colon, tumor | .vm-u | 777 to 1148 | 373 to 2 | 372/373 (99 %) | 0 diff (100 %id) | |||
AA609985 | .h | 970 to 1446 | 477 to 1 | 477/477 (100 %) | 0 diff (100 %id) | ||||
AA628450 | .vd-u | 3057 to 3544 | 488 to 1 | 488/488 (100 %) | 9 diff (98.2 %id) | ||||
AA621494 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vm-u | 812 to 1147 | 336 to 1 | 336/336 (100 %) | 0 diff (100 %id) | |||
AA587047 | colon, colon tumor RER+ | .vd-u | 3107 to 3544 | 438 to 1 | 438/438 (100 %) | 9 diff (98.0 %id) | |||
AA812256 | invasive tumor (cell line), Prostate | .vm-u | 779 to 1151 | 373 to 1 | 373/373 (100 %) | 0 diff (100 %id) | |||
AA757364 | pooled | .vm-u | 702 to 1150 | 448 to 1 | 448/448 (100 %) | 5 diff (98.9 %id) | |||
AA861552 | parathyroid gland, parathyroid tumor | .vd-u | 1754 to 1840 | 87 to 1 | 87/87 (100 %) | 0 diff (100 %id) | |||
AA904390 | pooled | .vm-u | 847 to 1150 | 308 to 5 | 304/308 (98 %) | 0 diff (100 %id) | |||
AA910057 | pooled | .vm-u | 807 to 1154 | 354 to 6 | 349/354 (98 %) | 0 diff (100 %id) | |||
AA918322 | pooled | .vm-u | 812 to 1154 | 344 to 2 | 343/344 (99 %) | 0 diff (100 %id) | |||
AI167136 | pooled | .vd-u | 1409 to 1840 | 432 to 1 | 432/432 (100 %) | 0 diff (100 %id) | |||
AA954024 | 2 pooled tumors (clear cell type), Kidney | .i | 706 to 1056 | 351 to 1 | 351/351 (100 %) | 0 diff (100 %id) | |||
AA988308 | breast | .vm-u | 806 to 1147 | 359 to 18 | AAA | 342/342 (100 %) | 0 diff (100 %id) | ||
AA993514 | .vm-u | 725 to 1154 | 435 to 7 | 429/435 (98 %) | 0 diff (100 %id) | ||||
AI027235 | .vd-u | 3121 to 3540 | 435 to 16 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 420/420 (100 %) | 1 diff (99.8 %id) | ||
AI027521 | parathyroid gland, parathyroid tumor | .vd-u | 1369 to 1840 | 472 to 1 | 472/472 (100 %) | 0 diff (100 %id) | |||
AI123812 | pooled | .vs-u | 1 to 478 | 477 to 1 | F23L N24I L25* | tiling clone, | 477/477 (100 %) | 3 diff (99.4 %id) | |
AI086314 | liver and spleen | .vd-u | 3266 to 3540 | 275 to 1 | 275/277 (99 %) | 12 diff (95.7 %id) | |||
AI055950 | .vd-u | 3086 to 3551 | 465 to 1 | 465/476 (97 %) | 8 diff (98.4 %id) | ||||
AI168772 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vm-u | 783 to 1152 | 370 to 1 | 370/370 (100 %) | 0 diff (100 %id) | |||
AI084440 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vm-u | 698 to 1151 | 454 to 1 | 454/455 (99 %) | 0 diff (100 %id) | |||
AI090490 | heart | .vm-u | 670 to 1153 | 484 to 1 | 484/484 (100 %) | 0 diff (100 %id) | |||
AI186231 | heart | .vm-u | 715 to 1154 | 443 to 4 | 440/443 (99 %) | 0 diff (100 %id) | |||
AI138973 | .vl-u | 2780 to 3140 | 361 to 1 | 361/363 (99 %) | 1 diff (99.8 %id) | ||||
AI263902 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vm-u | 671 to 1147 | 487 to 11 | AAA | 477/477 (100 %) | 0 diff (100 %id) | ||
AI250908 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vm-u | 700 to 1151 | 452 to 1 | 452/452 (100 %) | 0 diff (100 %id) | |||
AI273295 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .vm-u | 757 to 1154 | 399 to 2 | 398/399 (99 %) | 0 diff (100 %id) | |||
AI268824 | carcinoid, lung | .i | 716 to 1055 | 340 to 1 | 340/341 (99 %) | 11 diff (96.8 %id) | |||
AI351479 | .vs-u | 138 to 382 | 245 to 1 | 245/245 (100 %) | 2 diff (99.2 %id) | ||||
AI335847 | uterus | .vm-u | 815 to 1154 | 341 to 2 | 340/341 (99 %) | 0 diff (100 %id) | |||
AI494086 | uterus | .vm-u | 537 to 963 | 427 to 1 | 427/427 (100 %) | 0 diff (100 %id) | |||
AI375916 | mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus | .o | 1853 to 2507 | 654 to 1 | 654/661 (98 %) | 10 diff (98.5 %id) | |||
AI435502 | pooled | .vd-u | 1369 to 1840 | 472 to 1 | 472/472 (100 %) | 0 diff (100 %id) | |||
AI868258 | pooled | .vm-u | 801 to 1146 | 346 to 1 | 346/346 (100 %) | 0 diff (100 %id) | |||
AI452918 | pooled | .vm-u | 685 to 1146 | 462 to 1 | 462/462 (100 %) | 0 diff (100 %id) | |||
AI573270 | anaplastic oligodendroglioma, brain | .o | 989 to 1462 | 474 to 1 | 474/478 (99 %) | 2 diff (99.6 %id) | |||
AI918225 | anaplastic oligodendroglioma, brain | .o | 1261 to 1460 | 200 to 1 | 200/200 (100 %) | 6 diff (97.0 %id) | |||
AI537775 | poorly differentiated adenocarcinoma withsignet ring cell features, stomach | .vd-u | 3287 to 3540 | 271 to 18 | AAA | Possibly primed on the genome, locally A rich (20/22 A in genome downstream of last aligned base) | 254/264 (96 %) | 0 diff (100 %id) | |
AI674563 | Prostate | .vm-u | 669 to 1152 | 493 to 10 | 484/493 (98 %) | 0 diff (100 %id) | |||
AI703074 | carcinoid, lung | .i | 475 to 1055 | 581 to 1 | 581/599 (96 %) | 0 diff (100 %id) | |||
AI871574 | carcinoid, lung | .vm-u | 724 to 1099 | 376 to 1 | 376/376 (100 %) | 0 diff (100 %id) | |||
AI760007 | Kidney | .vm-u | 823 to 1109 | 288 to 1 | 288/288 (100 %) | 2 diff (99.4 %id) | |||
AI933235 | anaplastic oligodendroglioma, brain | .vd-u | 3328 to 3547 | 220 to 1 | 220/220 (100 %) | 0 diff (100 %id) | |||
AI949687 | 2 pooled tumors (clear cell type), Kidney | .vm-u | 601 to 1154 | 557 to 4 | 554/557 (99 %) | 0 diff (100 %id) | |||
AW028569 | fibrotheoma, ovary | .vd-u | 2907 to 3539 | 642 to 1 | 642/648 (99 %) | 14 diff (97.9 %id) | |||
AW013895 | .vm-u | 740 to 1151 | 427 to 16 | AAA | 412/412 (100 %) | 3 diff (99.3 %id) | |||
AW015460 | .o | 1210 to 1478 | 270 to 2 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 269/274 (98 %) | 0 diff (100 %id) | ||
AW341053 | carcinoid, lung | .o | 2666 to 3159 | 1 to 494 | Submitted on the opposite strand | 494/494 (100 %) | 0 diff (100 %id) | ||
AW467057 | 2 pooled tumors (clear cell type), Kidney | .vm-u | 791 to 1149 | 373 to 15 | AAA | 359/359 (100 %) | 0 diff (100 %id) | ||
AW628584 | pooled | .vm-u | 662 to 1150 | 489 to 1 | 489/489 (100 %) | 0 diff (100 %id) | |||
AW631313 | pooled | .vm-u | 708 to 1148 | 443 to 3 | 441/443 (99 %) | 0 diff (100 %id) | |||
BF507389 | .vm-u | 191 to 431 | 11 to 251 | Submitted on the opposite strand | 241/251 (96 %) | 8 diff (96.9 %id) | |||
BF515264 | .vm-u | 725 to 1151 | 444 to 18 | AAA | 427/427 (100 %) | 8 diff (98.2 %id) | |||
BF509895 | .vl-u | 2501 to 2872 | 1 to 371 | Submitted on the opposite strand | 371/371 (100 %) | 3 diff (99.2 %id) | |||
BE222333 | carcinoid, lung | .vm-u | 205 to 771 | 1 to 567 | Submitted on the opposite strand | 567/567 (100 %) | 0 diff (100 %id) | ||
BE466036 | pooled germ cell tumors | .vm-u | 705 to 1147 | 443 to 1 | 443/443 (100 %) | 1 diff (99.8 %id) | |||
CB044922 | colon, juvenile granulosa tumor | .vl-u | 2659 to 3153 | 495 to 1 | tiling clone, to resequence, | 495/495 (100 %) | 0 diff (100 %id) | ||
CB044923 | colon, juvenile granulosa tumor | .vl-u | 301 to 915 | 32 to 646 | exact | tiling clone, to resequence, | 615/646 (95 %) | 6 diff (99.1 %id) | |
BE671884 | pooled germ cell tumors | .vd-u | 1738 to 1834 | 97 to 1 | 97/97 (100 %) | 0 diff (100 %id) | |||
BE672030 | pooled germ cell tumors | .vm-u | 690 to 1147 | 458 to 1 | 458/458 (100 %) | 0 diff (100 %id) | |||
BE672587 | carcinoid, lung | .vm-u | 874 to 1083 | 284 to 75 | 210/212 (99 %) | 0 diff (100 %id) | |||
BG057515 | dorsal root ganglia | .vm-u | 723 to 1152 | 430 to 1 | 430/430 (100 %) | 0 diff (100 %id) | |||
BG149394 | carcinoid, lung | .vm-u | 295 to 640 | 1 to 346 | Submitted on the opposite strand | 346/346 (100 %) | 0 diff (100 %id) | ||
BF732426 | fibrotheoma, ovary | .vm-u | 309 to 810 | 1 to 502 | Submitted on the opposite strand | 502/502 (100 %) | 0 diff (100 %id) | ||
BF110529 | carcinoid, lung | .i | 700 to 1059 | 360 to 1 | 360/378 (95 %) | 8 diff (97.9 %id) | |||
BF437845 | Prostate | .vm-u | 1019 to 1154 | 141 to 6 | 136/141 (96 %) | 0 diff (100 %id) | |||
BF437870 | carcinoid, lung | .o | 2668 to 2835 | 1 to 169 | Submitted on the opposite strand | 169/174 (97 %) | 5 diff (97.2 %id) | ||
BF223368 | carcinoid, lung | .vm-u | 670 to 1154 | 485 to 1 | 485/485 (100 %) | 0 diff (100 %id) | |||
BE960969 | melanotic melanoma, high MDR, skin | .vm-u | 25 to 650 | 1 to 610 | L26C Y27T K28R V29F F30L ... | 610/664 (91 %) | 36 diff (94.6 %id) | ||
BE970005 | Pancreas | .vm-u | 208 to 843 | 1 to 630 | 630/881 (71 %) | 38 diff (95.7 %id) | |||
BF529584 | anaplastic oligodendroglioma with 1p/19qloss, brain | .o | 991 to 1567 | 62 to 640 | 579/640 (90 %) | 8 diff (98.8 %id) | |||
BF572534 | melanotic melanoma, high MDR, skin | .vm-u | 4 to 699 | 1 to 712 | L6W L8P Y9V K10V V11K ... | 712/745 (95 %) | 69 diff (90.8 %id) | ||
BF572719 | melanotic melanoma, high MDR, skin | .vm-u | 4 to 584 | 1 to 583 | L26W F30L K31S F32Y Y34* | 583/728 (80 %) | 36 diff (95.1 %id) | ||
BF696268 | brain, primitive neuroectoderm | .vd-u | 1291 to 1859 | 1 to 565 | 565/747 (75 %) | 12 diff (98.4 %id) | |||
BF696202 | brain, primitive neuroectoderm | .vd-u | 1291 to 1841 | 1 to 554 | 554/779 (71 %) | 9 diff (98.9 %id) | |||
BG115402 | duodenal adenocarcinoma, cell line, small intestine | .vd-u | 3114 to 3691 | 1 to 582 | 582/687 (84 %) | 28 diff (96.0 %id) | |||
BG178393 | adenocarcinoma, cell line, Prostate | .u | 1 to 668 | 1 to 665 | P188L H189T H190M V191S H192T ... | tiling clone, | 665/825 (80 %) | 4 diff (99.6 %id) | |
BG575400 | breast, mammary adenocarcinoma, cell line | .vd-u | 3246 to 3547 | 1 to 302 | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 302/302 (100 %) | 0 diff (100 %id) | |
BG681433 | skin, squamous cell carcinoma | .vm-u | 126 to 701 | 1 to 587 | Y9* | 587/1067 (55 %) | 19 diff (98.3 %id) | ||
BG681608 | skin, squamous cell carcinoma | .vm-u | 127 to 803 | 1 to 682 | Y9* | 682/682 (100 %) | 20 diff (97.1 %id) | ||
BI258675 | cervical carcinoma cell line, cervix | .h | 1324 to 2015 | 1 to 689 | 689/699 (98 %) | 25 diff (96.5 %id) | |||
BI255317 | cervical carcinoma cell line, cervix | .vd-u | 3101 to 3742 | 1 to 643 | 643/646 (99 %) | 6 diff (99.1 %id) | |||
BM453481 | leiomyosarcoma, uterus | .o | 424 to 998 | 1 to 576 | 576/958 (60 %) | 7 diff (99.3 %id) | |||
BM142562 | Islets of Langerhans, Pancreas | .vm-u | 616 to 1154 | 541 to 3 | 539/541 (99 %) | 0 diff (100 %id) | |||
CK820294 | Islets of Langerhans, Pancreas | .vm-u | 559 to 1154 | 598 to 3 | 596/598 (99 %) | 0 diff (100 %id) | |||
CK820295 | Islets of Langerhans, Pancreas | .o | 1776 to 2362 | 12 to 598 | tiling clone, | 587/598 (98 %) | 6 diff (99.0 %id) | ||
BQ277194 | mixed (pool of 40 RNAs) | .o | 1266 to 1439 | 1 to 174 | 174/225 (77 %) | 0 diff (100 %id) | |||
BQ021745 | lung, Metastatic Chondrosarcoma | .vm-u | 496 to 1149 | 669 to 17 | AAA | 653/653 (100 %) | 2 diff (99.7 %id) | ||
BQ227055 | melanotic melanoma, skin | .vd-u | 768 to 1623 | 24 to 892 | 869/892 (97 %) | 6 diff (99.4 %id) | |||
CA771032 | Pancreas, Purified pancreatic islet | .vm-u | 558 to 1149 | 592 to 1 | 592/592 (100 %) | 0 diff (100 %id) | |||
BQ435233 | melanotic melanoma, skin | .i | 1325 to 2122 | 24 to 824 | tiling clone, | 801/868 (92 %) | 22 diff (97.5 %id) | ||
BU195676 | leiomyosarcoma, uterus | .o | 1111 to 1950 | 1 to 845 | 845/910 (92 %) | 9 diff (99.1 %id) | |||
BU173366 | leiomyosarcoma, uterus | .vm-u | 100 to 1001 | 1 to 904 | exact | 904/907 (99 %) | 12 diff (98.7 %id) | ||
BQ721752 | dorsal root ganglia | .o | 1348 to 2182 | 19 to 863 | 845/982 (86 %) | 18 diff (98.2 %id) | |||
BQ900611 | eye, retinoblastoma | .o | 53 to 762 | 1 to 711 | 711/925 (76 %) | 4 diff (99.6 %id) | |||
CA867517 | Pancreas, Purified pancreatic islet | .vd-u | 1838 to 2324 | 1 to 487 | tiling clone, fully sequenced, | 487/487 (100 %) | 0 diff (100 %id) | ||
CA943533 | Pancreas, Purified pancreatic islet | .vd-u | 2294 to 2794 | 501 to 1 | tiling clone, fully sequenced, | 501/501 (100 %) | 0 diff (100 %id) | ||
BU857114 | adenocarcinoma, cell line, breast | .d | 376 to 1191 | 822 to 1 | Submitted on the opposite strand | 822/888 (92 %) | 15 diff (98.4 %id) | ||
BU941731 | mixed (pool of 40 RNAs) | .o | 686 to 888 | 1 to 203 | 203/678 (29 %) | 2 diff (99.8 %id) | |||
CX869770 | embryonic stem | .o | 2210 to 2931 | 1 to 726 | 726/726 (100 %) | 4 diff (99.5 %id) | |||
CX783021 | human embryonic stem cells | .vl-u | 2686 to 3162 | 478 to 1 | tiling clone, fully sequenced, | 478/478 (100 %) | 5 diff (99.0 %id) | ||
CX783095 | human embryonic stem cells | .vl-u | 2011 to 2716 | 1 to 706 | tiling clone, fully sequenced, | 706/706 (100 %) | 1 diff (99.9 %id) | ||
CD242164 | Blood vessels - aorta, basilar and artery | .vm-u | 1 to 769 | 9 to 781 | F5L | 781/781 (100 %) | 12 diff (98.5 %id) | ||
CK004631 | brain/CNS, Human Brain - Frontal Cortex | .vm-u | 369 to 964 | 1 to 597 | 597/597 (100 %) | 3 diff (99.5 %id) | |||
CB130019 | Liver | .e | 11 to 547 | 1 to 532 | 532/532 (100 %) | 4 diff (99.3 %id) | |||
CB164047 | Liver | .vd-u | 938 to 1509 | 1 to 572 | 572/572 (100 %) | 1 diff (99.9 %id) | |||
DA650165 | .o | 605 to 998 | 2 to 395 | capped | 394/528 (74 %) | 7 diff (98.7 %id) | |||
NM_030756.4 | .a | 1 to 4004 | 1 to 4004 | exact | RefSeq, | 4004/4004 (100 %) | 0 diff (100 %id) | ||
NM_001146274.1 | .d | 31 to 4052 | 1 to 4022 | RefSeq, | 4022/4022 (100 %) | 0 diff (100 %id) | |||
NM_001146283.1 | .f | 1 to 4021 | 1 to 4021 | exact | RefSeq, | 4021/4021 (100 %) | 0 diff (100 %id) | ||
NM_001146284.1 | .h | 1 to 3919 | 1 to 3919 | exact | RefSeq, | 3919/3919 (100 %) | 0 diff (100 %id) | ||
NM_001146285.1 | .e | 5 to 3957 | 1 to 3953 | RefSeq, | 3953/3953 (100 %) | 0 diff (100 %id) | |||
NM_001146286.1 | .o | 1 to 3880 | 1 to 3880 | RefSeq, | 3880/3880 (100 %) | 0 diff (100 %id) | |||
DA727673 | .o | 1487 to 1985 | 2 to 501 | capped | 500/620 (80 %) | 18 diff (97.1 %id) | |||
DA756157 | .o | 473 to 1060 | 2 to 591 | capped | 590/590 (100 %) | 2 diff (99.7 %id) | |||
CV572562 | cornea, eye | .d | 1419 to 2018 | 1 to 600 | tiling clone, | 600/600 (100 %) | 0 diff (100 %id) | ||
CD723168 | eye, lacrimal gland | .o | 16 to 611 | 1 to 596 | 596/596 (100 %) | 2 diff (99.7 %id) | |||
BM846392 | myeloma | .vd-u | 3270 to 3767 | 1 to 505 | tiling clone, | 505/505 (100 %) | 7 diff (98.7 %id) | ||
DA906633 | .e | 3 to 583 | 2 to 581 | capped | 580/580 (100 %) | 3 diff (99.5 %id) | |||
DC296234 | synovial membrane tissue from rheumatioidarthritis | .q | 1 to 559 | 1 to 559 | 559/559 (100 %) | 0 diff (100 %id) | |||
DC296235 | synovial membrane tissue from rheumatioidarthritis | .q | 1 to 474 | 1 to 474 | 474/475 (99 %) | 1 diff (99.8 %id) | |||
DA994870 | synovial membrane tissue from rheumatioidarthritis | .va | 1 to 549 | 2 to 550 | tiling clone, capped | 549/549 (100 %) | 0 diff (100 %id) | ||
DN997415 | breast cancer, Mammary gland (cancer tissue) | .d | 471 to 1089 | 8 to 624 | 617/624 (98 %) | 7 diff (98.9 %id) | |||
DR002538 | fetal brain | .o | 12 to 694 | 1 to 683 | 683/683 (100 %) | 6 diff (99.2 %id) | |||
DB009946 | colon, tumor tissue | .o | 96 to 620 | 2 to 526 | capped | 525/525 (100 %) | 0 diff (100 %id) | ||
DB014434 | esophageal, tumor tissue | .vd-u | 2951 to 3502 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DB337135 | testis | .vn | 566 to 1124 | 1 to 561 | tiling clone, | Submitted on the opposite strand | 561/561 (100 %) | 5 diff (99.2 %id) | |
BP362497 | thalamus | .vg | 1 to 583 | 1 to 583 | tiling clone, | 583/583 (100 %) | 1 diff (99.9 %id) | ||
DB125478 | thymus | .o | 551 to 998 | 2 to 449 | capped | 448/582 (76 %) | 6 diff (99.0 %id) | ||
TI_149289775 | .o | 660 to 1439 | 875 to 103 | 773/1070 (72 %) | 12 diff (98.9 %id) | ||||
TI_227713319 | .o | 2256 to 2996 | 57 to 796 | Submitted on the opposite strand | 740/1062 (69 %) | 11 diff (99.0 %id) | |||
DB168355 | kidney, tumor tissue | .vp | 1 to 575 | 2 to 576 | tiling clone, capped | 575/575 (100 %) | 0 diff (100 %id) | ||
DB169318 | kidney, tumor tissue | .va | 96 to 686 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | ||
DB169924 | kidney, tumor tissue | .e | 3 to 497 | 2 to 502 | capped | 501/501 (100 %) | 4 diff (99.3 %id) | ||
DB170164 | kidney, tumor tissue | .o | 2 to 479 | 2 to 481 | capped | 480/480 (100 %) | 1 diff (99.8 %id) | ||
DB171777 | kidney, tumor tissue | .vo | 1 to 583 | 2 to 584 | tiling clone, capped | 583/583 (100 %) | 0 diff (100 %id) | ||
DB174130 | kidney, tumor tissue | .va | 58 to 629 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
DB174611 | kidney, tumor tissue | .o | 338 to 854 | 2 to 521 | capped | 520/520 (100 %) | 4 diff (99.3 %id) | ||
DB174902 | kidney, tumor tissue | .vo | 1 to 575 | 2 to 576 | capped | 575/575 (100 %) | 0 diff (100 %id) | ||
DB179984 | kidney, tumor tissue | .r | 315 to 870 | 2 to 557 | capped | 556/556 (100 %) | 1 diff (99.9 %id) | ||
DB197717 | trachea | .o | 562 to 1147 | 2 to 587 | capped | 586/586 (100 %) | 0 diff (100 %id) | ||
BM968342 | lung, Primary Lung Epithelial Cells | .o | 2199 to 2844 | 11 to 660 | Submitted on the opposite strand | 650/660 (98 %) | 6 diff (99.1 %id) | ||
BM984731 | lung | .o | 451 to 1098 | 14 to 659 | Submitted on the opposite strand | 646/646 (100 %) | 3 diff (99.6 %id) | ||
BM971120 | lung | .o | 883 to 1439 | 592 to 35 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 558/674 (82 %) | 4 diff (99.5 %id) | |
CA450439 | Human Lung Epithelial cells, lung | .vm-u | 412 to 1151 | 755 to 17 | AAA | 739/739 (100 %) | 5 diff (99.4 %id) | ||
CB241789 | Human Lung Epithelial cells, lung | .vm-u | 963 to 1151 | 205 to 17 | AAA | 189/206 (91 %) | 5 diff (97.6 %id) | ||
CB242014 | Human Lung Epithelial cells, lung | .vm-u | 963 to 1151 | 205 to 17 | AAA | 189/206 (91 %) | 5 diff (97.6 %id) | ||
BM671072 | eye, optic nerve | .vd-u | 3371 to 3547 | 188 to 12 | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 177/177 (100 %) | 0 diff (100 %id) | |
BM701919 | eye, optic nerve | .a | 1781 to 2408 | 1 to 628 | 628/628 (100 %) | 0 diff (100 %id) | |||
BU729078 | eye, optic nerve | .vd-u | 3238 to 3547 | 321 to 12 | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 310/310 (100 %) | 3 diff (99.1 %id) | |
BM664955 | eye, optic nerve | .e | 2060 to 2588 | 540 to 12 | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 529/529 (100 %) | 0 diff (100 %id) | |
BM702280 | eye, optic nerve | .e | 1292 to 1911 | 1 to 620 | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 620/620 (100 %) | 0 diff (100 %id) | ||
BM717039 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vd-u | 2710 to 3456 | 1 to 745 | tiling clone, | 745/745 (100 %) | 4 diff (99.5 %id) | ||
BM681576 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .o | 2039 to 2522 | 483 to 1 | fully sequenced, | 483/483 (100 %) | 2 diff (99.6 %id) | ||
BM726406 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .o | 1540 to 2069 | 1 to 531 | fully sequenced, | 531/531 (100 %) | 1 diff (99.9 %id) | ||
BQ189036 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .o | 991 to 1476 | 29 to 513 | 485/516 (93 %) | 12 diff (97.7 %id) | |||
BQ187982 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vm-u | 419 to 1020 | 1 to 602 | 602/602 (100 %) | 4 diff (99.4 %id) | |||
BM722403 | eye, fetal eye | .vm-u | 1 to 566 | 7 to 571 | exact | 571/571 (100 %) | 1 diff (99.9 %id) | ||
BM679756 | eye, fetal eye | .o | 3235 to 3877 | 659 to 17 | tiling clone, fully sequenced, AAA | 643/643 (100 %) | 0 diff (100 %id) | ||
BM724533 | eye, fetal eye | .o | 2649 to 3265 | 6 to 621 | tiling clone, fully sequenced, | 616/621 (99 %) | 4 diff (99.4 %id) | ||
BU617649 | Bone, Subchondral Bone | .vm-u | 427 to 1151 | 743 to 19 | AAA | 725/725 (100 %) | 1 diff (99.9 %id) | ||
CA442250 | lung, Lung Focal Fibrosis | .vm-u | 159 to 810 | 1 to 650 | S3F | Submitted on the opposite strand | 650/650 (100 %) | 7 diff (99.0 %id) | |
CA444840 | lung, Metastatic Chondrosarcoma | .o | 2656 to 3023 | 1 to 368 | Submitted on the opposite strand | 368/368 (100 %) | 8 diff (97.9 %id) | ||
CA424317 | cell lines, Chondrosarcoma | .vd-u | 3026 to 3558 | 533 to 1 | 533/533 (100 %) | 2 diff (99.7 %id) | |||
BU619011 | Cell Line, Chondrosarcoma | .vm-u | 519 to 1147 | 647 to 19 | AAA | 629/629 (100 %) | 0 diff (100 %id) | ||
BU619467 | Cell Line, Chondrosarcoma | .o | 2199 to 2951 | 1 to 753 | tiling clone, | Submitted on the opposite strand | 753/753 (100 %) | 1 diff (99.9 %id) | |
CD367633 | Alveolar Macrophage, lung | .o | 2256 to 2923 | 1 to 670 | Submitted on the opposite strand | 670/670 (100 %) | 4 diff (99.5 %id) | ||
DB275258 | uterus | .o | 50 to 555 | 2 to 506 | capped | 505/505 (100 %) | 1 diff (99.9 %id) | ||
BP377043 | uterus | .ve | 1 to 581 | 1 to 581 | P127S | tiling clone, | 581/582 (99 %) | 2 diff (99.7 %id) | |
BP377044 | uterus | .ve | 1 to 579 | 1 to 579 | 579/583 (99 %) | 4 diff (99.4 %id) | |||
BP380373 | uterus | .t | 1 to 564 | 1 to 564 | tiling clone, | 564/564 (100 %) | 2 diff (99.7 %id) | ||
Y11306 | .a | 199 to 2640 | 1 to 2441 | L53E M344V S650W | tiling clone, | 2441/2444 (99 %) | 12 diff (99.6 %id) | ||
AA362301 | .vl-u | 2686 to 3162 | 478 to 1 | tiling clone, | Suspected internal deletion, this clone was ignored | 478/478 (100 %) | 5 diff (99.0 %id) | ||
AW881020 | ovary | .vl-u | 2011 to 2716 | 1 to 706 | tiling clone, | This clone was ignored | 706/706 (100 %) | 1 diff (99.9 %id) | |
AW881155 | ovary | .vm-u | 1 to 769 | 9 to 781 | This clone was ignored | 781/781 (100 %) | 12 diff (98.5 %id) | ||
BG217676 | .vm-u | 369 to 964 | 1 to 597 | Suspected internal deletion, suspected internal deletion, suspected internal deletion, this clone was ignored | 597/597 (100 %) | 3 diff (99.5 %id) | |||
AV721430 | hypothalamus | .vm-u | 369 to 964 | 1 to 597 | Suspected internal deletion, this clone was ignored | 597/597 (100 %) | 3 diff (99.5 %id) | ||
AA664011 | lung | .e | 11 to 547 | 1 to 532 | Suspected internal deletion, this clone was ignored | 532/532 (100 %) | 4 diff (99.3 %id) | ||
BF980896 | duodenal adenocarcinoma, cell line, small intestine | .vd-u | 938 to 1509 | 1 to 572 | Suspected internal deletion, this clone was ignored | 572/572 (100 %) | 1 diff (99.9 %id) | ||
DA650165 | .o | 605 to 998 | 2 to 395 | capped | 394/528 (74 %) | 7 diff (98.7 %id) | |||
NM_030756.4 | .a | 1 to 4004 | 1 to 4004 | exact | RefSeq, | 4004/4004 (100 %) | 0 diff (100 %id) | ||
NM_001146274.1 | .d | 31 to 4052 | 1 to 4022 | RefSeq, | 4022/4022 (100 %) | 0 diff (100 %id) | |||
NM_001146283.1 | .f | 1 to 4021 | 1 to 4021 | exact | RefSeq, | 4021/4021 (100 %) | 0 diff (100 %id) | ||
NM_001146284.1 | .h | 1 to 3919 | 1 to 3919 | exact | RefSeq, | 3919/3919 (100 %) | 0 diff (100 %id) | ||
NM_001146285.1 | .e | 5 to 3957 | 1 to 3953 | RefSeq, | 3953/3953 (100 %) | 0 diff (100 %id) | |||
NM_001146286.1 | .o | 1 to 3880 | 1 to 3880 | RefSeq, | 3880/3880 (100 %) | 0 diff (100 %id) | |||
DA727673 | .o | 1487 to 1985 | 2 to 501 | capped | 500/620 (80 %) | 18 diff (97.1 %id) | |||
DA756157 | .o | 473 to 1060 | 2 to 591 | capped | 590/590 (100 %) | 2 diff (99.7 %id) | |||
CV572562 | cornea, eye | .d | 1419 to 2018 | 1 to 600 | tiling clone, | 600/600 (100 %) | 0 diff (100 %id) | ||
CV572562 | cornea, eye | .d | 1419 to 2018 | 1 to 600 | tiling clone, | 600/600 (100 %) | 0 diff (100 %id) | ||
CD723168 | eye, lacrimal gland | .o | 16 to 611 | 1 to 596 | 596/596 (100 %) | 2 diff (99.7 %id) | |||
CD723168 | eye, lacrimal gland | .o | 16 to 611 | 1 to 596 | 596/596 (100 %) | 2 diff (99.7 %id) | |||
BM846392 | myeloma | .vd-u | 3270 to 3767 | 1 to 505 | tiling clone, | 505/505 (100 %) | 7 diff (98.7 %id) | ||
DA906633 | .e | 3 to 583 | 2 to 581 | capped | 580/580 (100 %) | 3 diff (99.5 %id) | |||
DC296234 | synovial membrane tissue from rheumatioidarthritis | .q | 1 to 559 | 1 to 559 | 559/559 (100 %) | 0 diff (100 %id) | |||
DC296235 | synovial membrane tissue from rheumatioidarthritis | .q | 1 to 474 | 1 to 474 | 474/475 (99 %) | 1 diff (99.8 %id) | |||
DA994870 | synovial membrane tissue from rheumatioidarthritis | .va | 1 to 549 | 2 to 550 | tiling clone, capped | 549/549 (100 %) | 0 diff (100 %id) | ||
DN997415 | breast cancer, Mammary gland (cancer tissue) | .d | 471 to 1089 | 8 to 624 | 617/624 (98 %) | 7 diff (98.9 %id) | |||
DN997415 | breast cancer, Mammary gland (cancer tissue) | .d | 471 to 1089 | 8 to 624 | 617/624 (98 %) | 7 diff (98.9 %id) | |||
DR002538 | fetal brain | .o | 12 to 694 | 1 to 683 | 683/683 (100 %) | 6 diff (99.2 %id) | |||
DB009946 | colon, tumor tissue | .o | 96 to 620 | 2 to 526 | capped | 525/525 (100 %) | 0 diff (100 %id) | ||
DB014434 | esophageal, tumor tissue | .vd-u | 2951 to 3502 | 2 to 553 | capped | 552/552 (100 %) | 0 diff (100 %id) | ||
DB337135 | testis | .vn | 566 to 1124 | 1 to 561 | tiling clone, | Submitted on the opposite strand | 561/561 (100 %) | 5 diff (99.2 %id) | |
BP362497 | thalamus | .vg | 1 to 583 | 1 to 583 | tiling clone, | 583/583 (100 %) | 1 diff (99.9 %id) | ||
DB125478 | thymus | .o | 551 to 998 | 2 to 449 | capped | 448/582 (76 %) | 6 diff (99.0 %id) | ||
TI_149289775 | .o | 660 to 1439 | 875 to 103 | 773/1070 (72 %) | 12 diff (98.9 %id) | ||||
TI_227713319 | .o | 2256 to 2996 | 57 to 796 | Submitted on the opposite strand | 740/1062 (69 %) | 11 diff (99.0 %id) | |||
DB168355 | kidney, tumor tissue | .vp | 1 to 575 | 2 to 576 | tiling clone, capped | 575/575 (100 %) | 0 diff (100 %id) | ||
DB169318 | kidney, tumor tissue | .va | 96 to 686 | 2 to 592 | capped | 591/591 (100 %) | 0 diff (100 %id) | ||
DB169924 | kidney, tumor tissue | .e | 3 to 497 | 2 to 502 | capped | 501/501 (100 %) | 4 diff (99.3 %id) | ||
DB170164 | kidney, tumor tissue | .o | 2 to 479 | 2 to 481 | capped | 480/480 (100 %) | 1 diff (99.8 %id) | ||
DB171777 | kidney, tumor tissue | .vo | 1 to 583 | 2 to 584 | tiling clone, capped | 583/583 (100 %) | 0 diff (100 %id) | ||
DB174130 | kidney, tumor tissue | .va | 58 to 629 | 2 to 573 | capped | 572/572 (100 %) | 0 diff (100 %id) | ||
DB174611 | kidney, tumor tissue | .o | 338 to 854 | 2 to 521 | capped | 520/520 (100 %) | 4 diff (99.3 %id) | ||
DB174902 | kidney, tumor tissue | .vo | 1 to 575 | 2 to 576 | capped | 575/575 (100 %) | 0 diff (100 %id) | ||
DB179984 | kidney, tumor tissue | .r | 315 to 870 | 2 to 557 | capped | 556/556 (100 %) | 1 diff (99.9 %id) | ||
DB197717 | trachea | .o | 562 to 1147 | 2 to 587 | capped | 586/586 (100 %) | 0 diff (100 %id) | ||
BM968342 | lung, Primary Lung Epithelial Cells | .o | 2199 to 2844 | 11 to 660 | Submitted on the opposite strand | 650/660 (98 %) | 6 diff (99.1 %id) | ||
BM968342 | lung, Primary Lung Epithelial Cells | .o | 2199 to 2844 | 11 to 660 | Submitted on the opposite strand | 650/660 (98 %) | 6 diff (99.1 %id) | ||
BM984731 | lung | .o | 451 to 1098 | 14 to 659 | Submitted on the opposite strand | 646/646 (100 %) | 3 diff (99.6 %id) | ||
BM971120 | lung | .o | 883 to 1439 | 592 to 35 | AAA | Internal priming: the 3' end of the oligo dT primed clone lies in the CDS | 558/674 (82 %) | 4 diff (99.5 %id) | |
CA450439 | Human Lung Epithelial cells, lung | .vm-u | 412 to 1151 | 755 to 17 | AAA | 739/739 (100 %) | 5 diff (99.4 %id) | ||
CA450439 | Human Lung Epithelial cells, lung | .vm-u | 412 to 1151 | 755 to 17 | AAA | 739/739 (100 %) | 5 diff (99.4 %id) | ||
CB241789 | Human Lung Epithelial cells, lung | .vm-u | 963 to 1151 | 205 to 17 | AAA | 189/206 (91 %) | 5 diff (97.6 %id) | ||
CB241789 | Human Lung Epithelial cells, lung | .vm-u | 963 to 1151 | 205 to 17 | AAA | 189/206 (91 %) | 5 diff (97.6 %id) | ||
CB242014 | Human Lung Epithelial cells, lung | .vm-u | 963 to 1151 | 205 to 17 | AAA | 189/206 (91 %) | 5 diff (97.6 %id) | ||
CB242014 | Human Lung Epithelial cells, lung | .vm-u | 963 to 1151 | 205 to 17 | AAA | 189/206 (91 %) | 5 diff (97.6 %id) | ||
BM671072 | eye, optic nerve | .vd-u | 3371 to 3547 | 188 to 12 | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 177/177 (100 %) | 0 diff (100 %id) | |
BM671072 | eye, optic nerve | .vd-u | 3371 to 3547 | 188 to 12 | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 177/177 (100 %) | 0 diff (100 %id) | |
BM701919 | eye, optic nerve | .a | 1781 to 2408 | 1 to 628 | 628/628 (100 %) | 0 diff (100 %id) | |||
BM701919 | eye, optic nerve | .a | 1781 to 2408 | 1 to 628 | 628/628 (100 %) | 0 diff (100 %id) | |||
BU729078 | eye, optic nerve | .vd-u | 3238 to 3547 | 321 to 12 | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 310/310 (100 %) | 3 diff (99.1 %id) | |
BU729078 | eye, optic nerve | .vd-u | 3238 to 3547 | 321 to 12 | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 310/310 (100 %) | 3 diff (99.1 %id) | |
BM664955 | eye, optic nerve | .e | 2060 to 2588 | 540 to 12 | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 529/529 (100 %) | 0 diff (100 %id) | |
BM664955 | eye, optic nerve | .e | 2060 to 2588 | 540 to 12 | AAA | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 529/529 (100 %) | 0 diff (100 %id) | |
BM702280 | eye, optic nerve | .e | 1292 to 1911 | 1 to 620 | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 620/620 (100 %) | 0 diff (100 %id) | ||
BM702280 | eye, optic nerve | .e | 1292 to 1911 | 1 to 620 | Possibly primed on the genome, locally A rich (14/15 A in genome downstream of last aligned base) | 620/620 (100 %) | 0 diff (100 %id) | ||
BM717039 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vd-u | 2710 to 3456 | 1 to 745 | tiling clone, | 745/745 (100 %) | 4 diff (99.5 %id) | ||
BM717039 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vd-u | 2710 to 3456 | 1 to 745 | tiling clone, | 745/745 (100 %) | 4 diff (99.5 %id) | ||
BM681576 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .o | 2039 to 2522 | 483 to 1 | fully sequenced, | 483/483 (100 %) | 2 diff (99.6 %id) | ||
BM681576 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .o | 2039 to 2522 | 483 to 1 | fully sequenced, | 483/483 (100 %) | 2 diff (99.6 %id) | ||
BM726406 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .o | 1540 to 2069 | 1 to 531 | fully sequenced, | 531/531 (100 %) | 1 diff (99.9 %id) | ||
BM726406 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .o | 1540 to 2069 | 1 to 531 | fully sequenced, | 531/531 (100 %) | 1 diff (99.9 %id) | ||
BQ189036 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .o | 991 to 1476 | 29 to 513 | 485/516 (93 %) | 12 diff (97.7 %id) | |||
BQ189036 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .o | 991 to 1476 | 29 to 513 | 485/516 (93 %) | 12 diff (97.7 %id) | |||
BQ187982 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vm-u | 419 to 1020 | 1 to 602 | 602/602 (100 %) | 4 diff (99.4 %id) | |||
BQ187982 | eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid | .vm-u | 419 to 1020 | 1 to 602 | 602/602 (100 %) | 4 diff (99.4 %id) | |||
BM722403 | eye, fetal eye | .vm-u | 1 to 566 | 7 to 571 | exact | 571/571 (100 %) | 1 diff (99.9 %id) | ||
BM722403 | eye, fetal eye | .vm-u | 1 to 566 | 7 to 571 | exact | 571/571 (100 %) | 1 diff (99.9 %id) | ||
BM679756 | eye, fetal eye | .o | 3235 to 3877 | 659 to 17 | tiling clone, fully sequenced, AAA | 643/643 (100 %) | 0 diff (100 %id) | ||
BM679756 | eye, fetal eye | .o | 3235 to 3877 | 659 to 17 | tiling clone, fully sequenced, AAA | 643/643 (100 %) | 0 diff (100 %id) | ||
BM724533 | eye, fetal eye | .o | 2649 to 3265 | 6 to 621 | tiling clone, fully sequenced, | 616/621 (99 %) | 4 diff (99.4 %id) | ||
BM724533 | eye, fetal eye | .o | 2649 to 3265 | 6 to 621 | tiling clone, fully sequenced, | 616/621 (99 %) | 4 diff (99.4 %id) | ||
BU617649 | Bone, Subchondral Bone | .vm-u | 427 to 1151 | 743 to 19 | AAA | 725/725 (100 %) | 1 diff (99.9 %id) | ||
BU617649 | Bone, Subchondral Bone | .vm-u | 427 to 1151 | 743 to 19 | AAA | 725/725 (100 %) | 1 diff (99.9 %id) | ||
CA442250 | lung, Lung Focal Fibrosis | .vm-u | 159 to 810 | 1 to 650 | S3F | Submitted on the opposite strand | 650/650 (100 %) | 7 diff (99.0 %id) | |
CA442250 | lung, Lung Focal Fibrosis | .vm-u | 159 to 810 | 1 to 650 | S3F | Submitted on the opposite strand | 650/650 (100 %) | 7 diff (99.0 %id) | |
CA444840 | lung, Metastatic Chondrosarcoma | .o | 2656 to 3023 | 1 to 368 | Submitted on the opposite strand | 368/368 (100 %) | 8 diff (97.9 %id) | ||
CA444840 | lung, Metastatic Chondrosarcoma | .o | 2656 to 3023 | 1 to 368 | Submitted on the opposite strand | 368/368 (100 %) | 8 diff (97.9 %id) | ||
CA424317 | cell lines, Chondrosarcoma | .vd-u | 3026 to 3558 | 533 to 1 | 533/533 (100 %) | 2 diff (99.7 %id) | |||
CA424317 | cell lines, Chondrosarcoma | .vd-u | 3026 to 3558 | 533 to 1 | 533/533 (100 %) | 2 diff (99.7 %id) | |||
BU619011 | Cell Line, Chondrosarcoma | .vm-u | 519 to 1147 | 647 to 19 | AAA | 629/629 (100 %) | 0 diff (100 %id) | ||
BU619011 | Cell Line, Chondrosarcoma | .vm-u | 519 to 1147 | 647 to 19 | AAA | 629/629 (100 %) | 0 diff (100 %id) | ||
BU619467 | Cell Line, Chondrosarcoma | .o | 2199 to 2951 | 1 to 753 | tiling clone, | Submitted on the opposite strand | 753/753 (100 %) | 1 diff (99.9 %id) | |
BU619467 | Cell Line, Chondrosarcoma | .o | 2199 to 2951 | 1 to 753 | tiling clone, | Submitted on the opposite strand | 753/753 (100 %) | 1 diff (99.9 %id) | |
CD367633 | Alveolar Macrophage, lung | .o | 2256 to 2923 | 1 to 670 | Submitted on the opposite strand | 670/670 (100 %) | 4 diff (99.5 %id) | ||
CD367633 | Alveolar Macrophage, lung | .o | 2256 to 2923 | 1 to 670 | Submitted on the opposite strand | 670/670 (100 %) | 4 diff (99.5 %id) | ||
DB275258 | uterus | .o | 50 to 555 | 2 to 506 | capped | 505/505 (100 %) | 1 diff (99.9 %id) | ||
BP377043 | uterus | .ve | 1 to 581 | 1 to 581 | P127S | tiling clone, | 581/582 (99 %) | 2 diff (99.7 %id) | |
BP377044 | uterus | .ve | 1 to 579 | 1 to 579 | 579/583 (99 %) | 4 diff (99.4 %id) | |||
BP380373 | uterus | .t | 1 to 564 | 1 to 564 | tiling clone, | 564/564 (100 %) | 2 diff (99.7 %id) | ||
Y11306 | .a | 199 to 2640 | 1 to 2441 | L53E M344V S650W | tiling clone, | 2441/2444 (99 %) | 12 diff (99.6 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd-u, .ve, .vf-u, .vg, .vh, .vi, .vj, .vk, .vl-u, .vm-u, .vn, .vo, .vp, .vq, .vr, .vs-u, .vt-u, .vu-u, .vv-u | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes DCI |